Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07355959

Clinical Study to Assess the Efficacy and Pressure Maintenance of MOBIDERM Autofit Versus Bandages in the Management of Breast Cancer Related Lymphedema (BCRL) in Night-time Maintenance Phase.

Cross-over, Randomized, Open Label Study to Assess the Efficacy and Pressure Maintenance of MOBIDERM Autofit Versus Bandages in the Management of Breast Cancer Related Lymphedema (BCRL) in Night-time Maintenance Phase.

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
16 (estimated)
Sponsor
Thuasne · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this cross-over, randomized study is to assess the efficacy and pressure maintenance of MOBIDERM Autofit versus bandages in the management of Breast Cancer Related Lymphedema (BCRL) in night-time maintenance phase.

Detailed description

In order to optimize treatment of lymphedema efficacy, THUASNE developed the standard Auto-Adjustable Armsleeve using the MOBIDERM technology, named MOBIDERM Autofit. The device has already been evaluated in several clinical studies as an adjuvant treatment to daily compressive garment during night-time maintenance phase in women with Breast cancer related lymphedema. The possibility to use this category of devices during both phases of lymphedema treatment has been reinforced recently by studies that showed a similar reduction in lymphedema volume with wraps versus conventional multilayer bandages \[Ochalek et al., 2023,Borman et al., 2021\]. The global objective of the MOBISCAN study is to reinforce the efficacy of MOBIDERM Autofit garment by assessing its efficacy and pressure maintenance versus bandages in the management of upper limb Lymphedema in night-time maintenance phase.

Conditions

Interventions

TypeNameDescription
DEVICEMOBIDERM Autofit ArmsleeveThe MOBIDERM Autofit Armsleeve will be worn by the patients at night for one month.
DEVICESelf-bandagesSelf-bandages will be worn by the patients at night for one month.

Timeline

Start date
2026-01-15
Primary completion
2026-07-01
Completion
2026-07-01
First posted
2026-01-21
Last updated
2026-01-29

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT07355959. Inclusion in this directory is not an endorsement.